Cut-off levels and diagnostic accuracy of infliximab trough levels and anti-infliximab antibodies in Crohn's disease

Casper Steenholdt, Klaus Bendtzen, Jørn Brynskov, Ole Østergaard Thomsen, Mark Andrew Ainsworth

180 Citationer (Scopus)

Abstract

Reasons for infliximab failure in Crohn's disease and ulcerative colitis are debated. Serum levels of infliximab and anti-infliximab antibodies have been associated with loss of response. We aimed at determining cut-off levels for infliximab and anti-infliximab antibody concentrations associated with clinical response to infliximab maintenance therapy.
OriginalsprogEngelsk
TidsskriftScandinavian Journal of Gastroenterology
Vol/bind46
Udgave nummer3
Sider (fra-til)310-8
Antal sider9
ISSN0036-5521
DOI
StatusUdgivet - 1 mar. 2011

Fingeraftryk

Dyk ned i forskningsemnerne om 'Cut-off levels and diagnostic accuracy of infliximab trough levels and anti-infliximab antibodies in Crohn's disease'. Sammen danner de et unikt fingeraftryk.

Citationsformater